Physician profile
Francis Collini
NPI 1023081684
$44,521.29
in general payments reported to CMS, 2019-2025
34 companies · $969 in 2025
The $969 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $16K · 2021: $7,237 · 2022: $761 · 2023: $334 · 2024: $632 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,935.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $40,999.61 | 2019-2025 | Collagenase Santyl, Stravix Pl, Oasis |
| Merz North America, INC. | $575.61 | 2019-2023 | |
| Allergan, INC. | $346.05 | 2019-2022 | |
| Organogenesis INC. | $279.01 | 2019-2025 | Puraply, Affinity, Cygnus Dual |
| Revance Therapeutics, INC. | $273.55 | 2024 | Daxxify |
| Convatec INC. | $242.83 | 2024-2025 | |
| Acelrx Pharmaceuticals, INC. | $224.50 | 2021 | |
| Abbvie INC. | $185.95 | 2023-2025 | |
| Integra Lifesciences Corporation | $154.01 | 2019-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $149.38 | 2025 | |
| Ethicon US, LLC | $107.06 | 2020-2025 | Ethicon, Vistaseal, Dermabond Prineo |
| Sientra, INC. | $97.61 | 2019-2020 | |
| Kci USA, INC. | $95.55 | 2021-2023 | V.A.C. Dermatac, Activ.A.C., Prevena |
| Axogen | $94.04 | 2019 | |
| Motiva USA, LLC | $86.74 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $80.00 | 2022 | |
| Osiris Therapeutics INC. | $76.38 | 2019 | |
| Reapplix INC. | $57.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $56.34 | 2021-2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $48.51 | 2022-2023 | Seglentis |
| Lumenis, INC | $40.79 | 2021 | |
| Tela Bio, INC. | $37.86 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Avita Medical Americas, LLC | $32.19 | 2024 | |
| Stryker Corporation | $27.93 | 2021 | |
| Lifenet Health | $23.62 | 2024 | Theragenesis Wound Matrix |
| Mentor Worldwide LLC | $22.55 | 2022 | |
| Polynovo North America LLC | $16.44 | 2024 | Novosorb Btm |
| Elutia, INC. | $15.43 | 2021 | |
| Acera Surgical, INC. | $14.98 | 2019 | |
| Axonics, INC. | $14.13 | 2023 | Axonics |
| Solventum Corporation | $14.06 | 2025 | V.A.C. Dermatac, Activ.A.C. |
| Acell, INC. | $11.86 | 2019 | |
| Pfizer INC. | $11.14 | 2019 | |
| Kerecis Limited | $7.65 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Collini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.